Clinical trials: Contraceptive Devices
Premenstrual Dysphoric Disorder ( PMDD)
YAZ Premenstrual Dysphoric Disorder (PMDD) in China
The purpose of this study is to evaluate the efficacy and safety of YAZ compared to placebo in the treatment of symptoms related to Premenstrual Dysphoric Disorder (PMDD).
- Trial name
- NCT00824187
- Testing
- EE20/DRSP(YAZ, BAY86-5300)
- Where
- 16 sites in China
- Volunteers
- 187 people
- Sponsor
- Bayer
Contraception
Open-label Study to Evaluate the Efficacy and Safety of an Extended-cycle, Low Dose Combination Oral Contraceptive
This is an open-label, single treatment study. All subjects will receive one year of oral contraceptive therapy with DR-1011. Study participants will receive physical and gynecological exams, including Pap smear.
- Trial name
- NCT00196326
- Testing
- DR-1011
- Where
- 55 sites in United States
- Volunteers
- 2,235 people, healthy volunteers welcome
- Sponsor
- Duramed Research
Reproductive Health
RH and Adolescents
This study will create a model of reproductive health services for HIV-positive female adolescents in Asia.
- Trial name
- NCT02713750
- Testing
- reversible contraceptive methods
- Where
- 4 sites in Thailand
- Volunteers
- 77 people
- Sponsor
- The HIV Netherlands Australia Thailand Research Collaboration
Quality of Life, Contraceptive Device; Complications
Impact of ESSURE Devices Withdrawal on the Symptomatology of Patients
The ESSURE device is a method of permanent contraception, marketed in France since 2005. Multiple side effects have been reported by patients since 2015 and the marketing was stopped in 2017.
- Trial name
- ESSURE (NCT03623126)
- Testing
- Questionnaire
- Where
- 2 sites in France
- Volunteers
- 41 people
- Sponsor
- Hospices Civils de Lyon
Etonogestrel Contraceptive Implant, Bothersome Bleeding
Use of Norethindrone Acetate for Management of Bleeding Associated With the Etonogestrel Contraceptive Implant
The overall objective of this study is to confirm that oral progesterone is an effective way to manage bothersome bleeding; thus increasing the rate of continuation of the etonogestrel contraceptive implant in adolescents.
- Trial name
- NCT02353247
- Testing
- Norethindrone acetate
- Where
- United States
- Volunteers
- 88 people
- Sponsor
- Norton Healthcare
Contraceptive Devices, Long-Acting Reversible Contraception
Nitrous Oxide for Pain Management During IUD Insertion in Nulliparous Adolescent Women
This pilot study aims to assess the feasibility, acceptability, and effectiveness of using nitrous oxide (N2O) sedation for intrauterine device (IUD) insertions for nulliparous adolescent and young adult women in a primary care…
- Conditions
- Contraceptive Devices, Long-Acting Reversible Contraception, Analgesia, Adolescent Health
- Trial name
- NCT04089852
- Testing
- Nitrous oxide gas for inhalation, Oxygen Gas for Inhalation
- Where
- United States
- Volunteers
- healthy volunteers welcome
- Sponsor
- Boston Children's Hospital
Infertility
Oral Microdose Lupron Versus Luteal Estradiol Trial in Poor Responder In Vitro Fertilization (IVF) Patients
Hundreds of thousands of couples in the United States experience infertility each year. When initial measures do not help, some couples require a process called ovarian stimulation and in vitro fertilization (IVF).
- Trial name
- OMLET (NCT00826839)
- Testing
- Oral contraceptive pill and microdose lupron, E2 patch/antagonist
- Where
- United States
- Sponsor
- Weill Medical College of Cornell University
Premenstrual Dysphoric Disorder
Continuous Oral Contraceptive Treatment in Premenstrual Dysphoric Disorder (PMDD)
The purpose of this study is to compare a low dose oral contraceptive (OC) given continuously (every day for three months) with the same low dose oral contraceptive given in an interrupted regimen (one week of inactive placebo…
- Trial name
- PMDD (NCT00927095)
- Testing
- Continuous OC (EE/DROS), Intermittent OC (EE/DROS)
- Where
- United States
- Volunteers
- 67 people
- Sponsor
- University of North Carolina, Chapel Hill
Oral Contraceptive
Oral Contraceptive (OC) Progestin Dose and Breast Proliferation
The purpose of this research study is to gain a better understanding of the changes that may occur in the breast when a woman uses an oral contraceptive (birth control pill).
- Trial name
- NCT00972439
- Testing
- Oral Contraceptive: Ortho-Novum® 1/35, Oral Contraceptive: Ovcon Fe®
- Where
- United States
- Volunteers
- 33 people, healthy volunteers welcome
- Sponsor
- University of Southern California
Mental Disorders, Contraception
Medication Safety and Contraceptive Counseling for Reproductive Aged Women With Psychiatric Conditions
There is currently limited research that addresses the unique medication safety and family planning needs among women of reproductive age with psychiatric conditions.
- Conditions
- Mental Disorders, Contraception, Chemical Teratogen Exposure
- Trial name
- MSRP (NCT02292056)
- Testing
- 1-on-1 counseling
- Where
- United States
- Volunteers
- 50 people
- Sponsor
- University of California, San Diego
Contraception
Group Versus Individual Contraceptive Counseling for Resettled African Refugee Women
To evaluate the feasibility and effectiveness of group contraceptive counseling on family planning knowledge acquisition, service satisfaction, method uptake and continuation among a group of resettled African refugee women.
- Trial name
- NCT02796586
- Testing
- Counseling
- Where
- United States
- Volunteers
- 17 people, healthy volunteers welcome
- Sponsor
- University of Utah
Dysmenorrhea
Continuous Administration of Oral Contraceptive, Primary Dysmenorrhea
The primary hypothesis is that continuous administration of an OCP (CCOCP regimen) will result in more pain relief than a traditional 21/7 administration in primary dysmenorrhea (PD) patients.
- Trial name
- Dysmenorrhea (NCT00517556)
- Testing
- CCOCP, Traditional OCP
- Where
- Croatia
- Volunteers
- 38 people, healthy volunteers welcome
- Sponsor
- Milton S. Hershey Medical Center
HIV Infections
Atazanavir and Ritonavir (ATV/RTV) and an Oral Contraceptive in Healthy Females
The purpose of this study is to administer a combined oral contraceptive (ethinyl estradiol and norgestimate) with the HIV treatment of atazanavir and ritonavir to healthy females in order to assess if the concentrations of the…
- Trial name
- NCT00357604
- Testing
- Ortho Tri-Cyclen (ethinyl estradiol + norgestimate), Ortho Tri-Cyclen LO (ethinyl estradiol + norgestimate) + Atazanavir/Ritonavir for 14 days then Ortho Tri-Cyclen for 7 days
- Where
- United States
- Volunteers
- 22 people, healthy volunteers welcome
- Sponsor
- Bristol-Myers Squibb
Healthy Volunteers
M0001 Effects on Oral Contraceptive Plasma Levels
This is a randomized, open-label, two-way cross-over drug-drug interaction Phase I trial. The objectives of this phase I trial are to investigate in healthy female subjects: the effect of prucalopride on the absorption of…
- Trial name
- NCT01036893
- Testing
- prucalopride
- Where
- Germany
- Volunteers
- 16 people, healthy volunteers welcome
- Sponsor
- Movetis
Reproductive Coercion, Intimate Partner Violence
Adapting, Expanding and Evaluating ARCHES in Kenya
Document evidence, via cluster randomized controlled trial, of the effectiveness of the ARCHES intervention, a brief, clinic-based counselling intervention demonstrated to reduce intimate partner violence and reproductive…
- Trial name
- NCT06059196
- Testing
- ARCHES (Addressing Reproductive Coercion in Health Settings), BCS+ (Balanced Counseling Strategy Plus)
- Where
- 24 sites in Kenya
- Volunteers
- 3,928 people
- Sponsor
- University of California, San Diego
Polycystic Ovary Syndrome (PCOS)
Efficacy of Oral Contraceptive, Progesterone, and Inositol on Menstrual Regulation in PCOS
This cross-sectional study aims to compare the effectiveness of oral contraceptives, oral progesterone (didrogesterone), and inositol in regulating menstrual cycles among women diagnosed with polycystic ovary syndrome (PCOS).
- Trial name
- NCT07242131
- Testing
- Combined Oral Contraceptive (Ethinylestradiol 0.03 mg + Drospirenone 3 mg), Inositol mid-level volume, Dydrogesterone Pill
- Where
- Turkey (Türkiye)
- Volunteers
- 150 people
- Sponsor
- Ege University
Dysmenorrhea
A Study to Evaluate the Efficacy of Seasonique for the Treatment of Cyclic Pelvic Pain
This study is being conducted to evaluate the effects of treatment with Seasonique an extended-regimen oral contraceptive that utilizes low dose ethinyl estradiol during the typical hormone-free interval.
- Trial name
- NCT00196365
- Testing
- levonorgestrel/EE 0.15/0.03 and EE 0.01 mg tablets
- Where
- 18 sites in United States
- Volunteers
- 97 people
- Sponsor
- Duramed Research
Removal of Contraceptive Implant
Removal of Palpable Subdermal Contraceptive Rod Implants.
There are no implant removal devices on the market by any manufacturer. New features are described in comparison with the existing removal technique.
- Trial name
- NCT02986971
- Testing
- New IMD
- Where
- Sweden
- Volunteers
- 22 people
- Sponsor
- RemovAid AS
Pregnancy
Post-abortion Care and Contraceptive Counselling by Midwives or Physicians
The aim of this project is to study the safety, efficacy and effectiveness of medical treatment of incomplete abortion provided to women by physicians or midwives in Kisumu, Kenya.
- Trial name
- NCT01865136
- Testing
- Medical Post Abortion Care
- Where
- Kenya
- Volunteers
- 890 people
- Sponsor
- Karolinska Institutet
Infertility
Predictive Factors for Ovarian Stimulation Using a Fixed Daily Dose of 200 IU Recombinant FSH (Study 142003)(P05696)
The success of assisted reproductive technologies (ART) is critically dependent on optimizing protocols for controlled ovarian stimulation to provide adequate numbers of good quality oocytes and embryos.
- Trial name
- Xpect (NCT00778999)
- Testing
- Marvelon
- Volunteers
- 442 people, healthy volunteers welcome
- Sponsor
- Organon and Co